CDC Just Awarded Pfizer $1.2 Billion for COVID-19 Shots
U.S. federal procurement records published in June 2026 show that the U.S. Centers for Disease Control and Prevention (CDC) awarded Pfizer more than $1.24 billion in contracts for adult and pediatric mRNA COVID-19 shots for fiscal years 2026 and 2027. The contracts, which were published on SAM.gov and contained more money allocated for pediatric COVID […]
Declassified U.S. Intelligence Documents Link Dr. Fauci to Coverup of SARS-CoV-2 Lab Leak
On June 18, 2026, outgoing Director of National Intelligence Tulsi Gabbard released a collection of declassified documents through the Office of the Director of National Intelligence (ODNI) alleging that former director of the U.S. National Institute of Allergy and Infectious Diseases (NIAID) Anthony Fauci, MD used intelligence agencies to suppress evidence that the mutated SARS-CoV-2 […]
AI Designed a Universal Coronavirus Vaccine for Viruses Not Yet in Existence
University of Cambridge researchers have developed what they describe as a “fundamentally new” type of vaccine designed exclusively using artificial intelligence (AI), marking the first time a vaccine’s active antigen was created entirely through computational modeling and tested in humans. The vaccine candidate, pEVAC-PS, was developed by DIOSynVax Ltd., a biotechnology company founded out of […]
U.S. Fertility Rates Near Historic Lows
Fertility rates in the United States are now among the lowest levels ever recorded, based on provisional data released by the U.S. Centers for Disease Control and Prevention (CDC) earlier this month. According to the CDC report, the general fertility rate declined to 53.1 births per 1,000 women ages 15-44, down 23 percent since 2007, […]
Pfizer, BioNTech End mRNA COVID-19 Biologic Trial Early
After failing to recruit enough eligible volunteers to generate enough data in the U.S. to meet U.S. Food and Drug Administration (FDA) post-marketing evidence requirements, Pfizer, Inc. and BioNTech SE have halted a large clinical trial of their updated mRNA COVID-19 biologic. The study targeted healthy adults 50 to 64 years of age but fell […]
Moderna’s mNEXSPIKE mRNA COVID-19 Shot Approved by European Commission
The European Commission (EC) has granted marketing authorization for Moderna’s mNEXSPIKE mRNA COVID-19 shot, allowing it to be marketed across the European Union (U.N.). The authorization follows a regulatory review and permits all 27 E.U. Member States, as well as Iceland, Liechtenstein and Norway, to consider the shot for use within their vaccination programs. It […]